FUNDRAISING FOR A CURE
Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them
UK researchers have identified genetic patterns that could help to predict the likelihood of someone developing pancreatic cancer.
Dr Zaed Hamady (pictured) and Dr William Tapper, of the NIHR Southampton Biomedical Research Centre and the University of Southampton, who led the research, believe the findings could eventually lead to earlier diagnosis and treatment.
In a study published in the journal Gastroenterology, they compared the genetic data of 1,042 people with pancreatic ductal adenocarcinoma cancer (PDAC) – the most common form of pancreatic cancer – with 10,420 healthy participants without cancer.
PDAC has the lowest survival rate of any cancer and, with no effective early diagnosis tools, it is usually detected at an advanced stage and has spread around the body.
It is also linked to new-onset diabetes and symptoms can include weight loss and changes to bowel habits, with vague symptoms often presenting difficulties in identifying the cancer early.
Using data from the UK Biobank, a database of genetic and health information from half a million participants nationwide, they looked for small variations in genes previously linked to the disease.
They then combined this genetic data with information on a person’s symptoms, lifestyle and medical history and used a computer model to establish what factors were most likely to increase a person’s risk of developing the cancer.
The researchers said the findings could pave the way for a secondary screening programme for patients with new-onset diabetes who may be at greater risk of developing pancreatic cancer.
“This study could change the way we diagnose people with pancreatic ductal adenocarcinoma,” said Dr Hamady, a consultant hepatobiliary, pancreatic and laparoscopic surgeon at University Hospital Southampton.
“It shows it is possible to develop a model which can predict who is most likely to develop the disease and, if used as a tool to aid diagnosis, this could greatly help to catch this cancer early at a time when treatment is most effective. This would help save lives.”
The researchers have now received £35,000 from the Liver and Pancreatic Research & Development Fund (LAPR&D) to progress the project and develop a dedicated risk score tool.
LAPR&D, which aims to deliver improvements in the prevention, diagnosis and treatment of cancers of the liver and pancreas, was set up by surgeon Mo Abu Hilal and a group of patients at University Hospital Southampton in 2012.
Previously a fund of Southampton Hospitals Charity, it has now been incorporated into the larger and independent PLANETS Cancer Charity which will look to support the research programme into the future.
Dr Tapper, associate professor in genomic informatics at the University of Southampton and project lead, said: “Pancreatic cancer remains a stubbornly difficult cancer to treat and, as with many cancers, early detection is crucial to improving patient outcomes.
“Often detection comes too late and survival rates remain low compared to other forms of cancer. Further innovative technology to predict people at risk of pancreatic cancer is particularly important for early detection.
“The aim is that this research programme will identify a group of people who will benefit from a screening programme without major financial impact on the public health system.”
Mr Nadir added: “I have been involved in several projects using artificial intelligence (AI) to interrogate health data and I am delighted to be appointed to conduct this new and exciting research in conjunction with LAPR&D.”
Neil Pearce, a recently retired consultant surgeon and co-founder of PLANETS Cancer Charity, said: “We are delighted to welcome LAPR&D on board as we have similar research and development goals while also providing patient support and looking after a wider range of cancers.
“It is an exciting partnership and we will now be looking to support and progress this excellent research programme moving forward.”
READ ABOUT HOW FUNDS ARE USED
PLANETS has thanked its supporters after completing a £1 million fundraising campaign and making the final payment for a pioneering radiotherapy machine. PLANETS Cancer Charity has been fundraising for the past six years to fully purchase Mobetron, a revolutionary mobile device which delivers radiotherapy during surgery – known as intraoperative radiotherapy (IORT). When the charity […]
Thank you to John Greenwood, Trustee of the The Hospital Saturday Fund, for visiting us on Monday and bringing this incredible grant of £10,000 to support our IORT (Intra Operative Radiotherapy) machine. This will enable us to continue delivering this lifesaving treatment at University Hospital Southampton – the only centre in the UK currently offering […]
PLANETS have funded a psychotherapy programme, after a successful pilot course, to help NET patients see their diagnosis in a ‘new view’. We all know that different people deal with their neuroendocrine cancer diagnosis very differently. Initially there are lots of scary tests and Doctor appointments. Then there are lots of talk about […]
A woman from Salisbury has become the first patient in the UK with head and neck cancer to receive radiotherapy in the operating theatre during surgery to remove a recurrent tumour. Jayne Garrett, 53, underwent major surgery at University Hospital Southampton on 25 April after suffering a recurrence of her cancer following conventional treatment […]
It was an honour to present the fantastic work and great initial results to medics from all over the country at our 1st National IORT (intra-operative radiotherapy) Symposium on Friday June 21st at University Hospital Southampton. After a lot of hard work and fundraising in order to bring IORT to the UK for the […]
A dietitian funded by PLANETS Cancer Charity and the Robert White Trust Fund is due to start work to develop and provide a comprehensive dietetic service to patients diagnosed with Neuroendocrine Cancer (NETs). Ruth Lee will be based at the Dorset NET service, which is part of the Wessex European Neuroendocrine tumour society centre […]
PLANETS are excited to share the news that University Hospital Southampton have secured £200,000 funding from the Robert White Trust for a research project that aims to gain a better understanding of NET biology which may lead to a greater range of treatment options for patients with this rare disease. Robert White was a former […]
We are thrilled and proud to update our supporters that a Southampton bowel cancer patient has become the first in the UK to receive radiotherapy during surgery using the IORT machine that PLANETS has funded. he 58-year-old male, who completed a combination of conventional chemotherapy and radiotherapy in August, underwent major surgery at Southampton […]
SOUTHAMPTON CLINICIANS PIONEER USE OF REVOLUTIONARY CANCER DEVICE PLANETS founders Neil Pearce and Brian Stedman, together with fund manager Layla Stephen successfully launched our long awaited IORT machine last night. The Mobetron is the first portable system able to administer the treatment in this way – known as intraoperative radiotherapy (IORT) – and will […]
PLANETS are thrilled to announce that the eagle (finally) has landed! 2 tons of intra-operative radio-therapy machine (IORT) arrived from the USA this week – currently undergoing acceptance testing. This is the UK’s first ever mobile electron beam radiotherapy machine for treating cancers during surgery. Thanks to everyone who has supported our fundraising which has […]
You may have notice that Southampton was mentioned in recent media stories regarding The National Tumour Bank that is carrying out important pancreatic cancer research? Colin Johnson, Professor of Surgical Sciences at University of Southampton, has this to say about the project: ‘The National Tissue Bank is a major development in pancreatic cancer research. Several […]
A big thank you to Sainsbury’s Hedge End for donating two digital radios to PLANETS to be used in the lead lined Gamma Scanner Rooms at Southampton General. Pictured presenting the radios to staff in the scanner rooms are PLANETS Fund Manager, Layla Stephen, and Dr Brian Stedman.
PLANETS Charitable Fund are excited to have committed to provide a grant over a two year period for a pancreatic research project: ́The role of Eps8 in αvβ6-dependent functions in pancreatic cancer invasion’ to be undertaken by Dr Jo Tod. Pancreatic adenocarcinoma (PC) has one of the worst outcomes of any cancer; only 3.7% of patients […]
[social_button button=”facebook” flayout=”standard ” fwidth=”450″ faction=”like” fcolorsheme=”light”] UHS magazine Connect featured a fantastic article about NET patient Maureen McKenzie who, in July 2013, became the first Southampton patient to receive PRRT (peptide receptor radionuclide therapy). The equipment for this treatment was jointly funded by UHS and PLANETS showing just how important and valuable the […]
[social_button button=”facebook” flayout=”standard ” fwidth=”450″ faction=”like” fcolorsheme=”light”] Pancreatic cancer affects over 8000 patients each year in the uk and remains the fifth biggest cancer killer in the UK, despite this its has been underfunded for many years and currently receives just 1% of total cancer research funding in the UK. NETs are a rare form […]
Subscribe to our Newsletter
Get informed about the latest news straight to your inbox